Claudia Zylberberg PhD

Claudia Zylberberg, PhD, serves as Founder and Chief Executive Officer and President of Akron Biotechnology, LLC, a company that develops, manufactures and markets bio-tools and high-end cell culture products under cGMP for the regenerative medicine industry. Dr. Zylberberg co-founded Akron Clinical, today CTIFacts Latam a clinical CRO specializing in cell therapy clinical trials in Latin America.

She also co-founded AssureImmune, a family stem cell bank that engages in R&D of cell therapies for the use of adult stem cell. With a PhD in Biotechnology from the University of British Columbia and University of Buenos Aires, Dr. Zylberberg has over 30 years of experience in the international biopharmaceutical industry. Her expertise is focused on the areas of recombinant protein production and human-derived blood products.